Φορτώνει......
Dasatinib dose management for the treatment of chronic myeloid leukemia
Chronic myeloid leukemia (CML) has evolved into a chronic disease that is managed with tyrosine kinase inhibitor therapy. Now that long‐term survival has been achieved in patients with CML, the focus of treatment has shifted to dose optimization, with the goal of maintaining response while improving...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5901015/ https://ncbi.nlm.nih.gov/pubmed/29370463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31232 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|